Effect of Bicalutamide Combined with Docetaxel on Serum PSA and VEGF Levels in Patients with Advanced Prostate Carcinoma

Table 1

Comparison of baseline data.

Items	Experimental group ()	Control group ()
Age (, years)			0.735	0.464
BMI (kg/m^2)			1.199	0.234
Mean disease duration (years)			0.191	0.849
Clinical stages			0.049	0.824
Stage C	30 (66.67%)	29 (64.44%)
Stage D	15 (33.33%)	16 (35.56%)
Number of comorbidities (types)			0.438	0.662
Education levels			0.048	0.827
High school and above	29 (62.22%)	28 (64.44%)
Middle school and below	16 (37.78%)	17 (35.56%)
Career
Civil servants	9 (20.00%)	10 (22.22%)	0.067	0.796
Workers	8 (17.78%)	9 (20.00%)	0.073	0.788
Farmers	6 (13.33%)	7 (15.56%)	0.089	0.764
Individual business owners	7 (15.56%)	5 (11.11%)	0.385	0.535
Other	15 (33.33%)	14 (31.11%)	0.051	0.822
Religious beliefs			0.062	0.803
Yes	10 (22.22%)	11 (24.44%)
No	35 (77.78%)	34 (75.56%)
Family income			0.045	0.832
(≥3000 yuan/man·month)	21 (46.67%)	20 (44.44%)
(<3000yuan/man·month)	24 (53.33%)	25 (55.56%)
Smoking			0.216	0.642
Yes	33 (73.33%)	31 (68.89%)
No	12 (26.67%)	14 (31.11%)
Drinking			0.073	0.788
Yes	36 (80.00%)	37 (82.22%)
No	9 (20.00%)	8 (17.78%)
Residence			0.178	0.673
Urban areas	21 (46.67%)	23 (51.11%)
Rural areas	24 (53.33%)	22 (48.89%)